SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-12-422182
Filing Date
2012-10-12
Accepted
2012-10-12 17:10:12
Documents
4
Effectiveness Date
2012-10-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d423967ddefa14a.htm DEFA14A 24542
2 GRAPHIC g423967g78t57.jpg GRAPHIC 6766
3 GRAPHIC g423967g90t56.jpg GRAPHIC 3644
4 GRAPHIC g423967g97t60.jpg GRAPHIC 4398
  Complete submission text file 0001193125-12-422182.txt   46680
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35285 | Film No.: 121142338
SIC: 2836 Biological Products, (No Diagnostic Substances)